Q: What is Viibryd used for?

Viibryd is used to treat major depressive disorder .

Q: How does Viibryd work?

Mechanism of Action Viibryd (vilazodone) is classified as both a selective serotonin reuptake inhibitor (SSRI) and a partial serotonin agonist. While the exact way it works to treat depression is not fully understood, it is believed to affect the brain's chemical messengers in the following ways: Increasing Serotonin Levels: Like other SSRIs, Viibryd prevents the brain from reabsorbing serotonin too quickly. This allows more serotonin to remain available to transmit signals between nerve cells. Targeting Specific Receptors: Viibryd also binds to specific serotonin receptors called 5-HT1A receptors. By acting as a partial agonist at these sites, it may help further modulate serotonin activity in the brain. Serotonin is a natural substance that helps maintain mental balance. By enhancing serotonin activity, Viibryd helps improve mood and reduce the symptoms of major depressive disorder.

Q: What are the active ingredients in Viibryd?

The active ingredient in Viibryd is vilazodone .

Q: What are the side effects of Viibryd?

Common side effects of Viibryd may include: Diarrhea Nausea Insomnia Always consult with a healthcare professional about potential side effects.

Q: What drug class is Viibryd?

Viibryd belongs to the SSRI and 5-HT1A receptor partial agonist drug class.

Q: What is the dosage of Viibryd and how do I take it?

How to Take Viibryd Viibryd is a tablet taken by mouth, usually once per day. It is important to follow the instructions on your prescription label and take the medication exactly as directed by your healthcare provider. To help you remember your dose, try to take it at the same time every day. Taking with Food You must take Viibryd with food. Taking this medication on an empty stomach can significantly reduce the amount of medicine your body absorbs, which may make the treatment less effective. Missed Dose If you miss a dose of Viibryd, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one. General Instructions Swallow the tablets whole; do not crush or chew them unless instructed otherwise by a healthcare professional. Continue taking the medication even if you begin to feel better. Do not stop taking this medication without first consulting your doctor, as they may want to gradually reduce your dose.

Q: Is Viibryd safe during pregnancy and breastfeeding?

Pregnancy Research regarding the use of Viibryd during pregnancy is limited. Taking similar antidepressant medications during the third trimester may lead to complications in the newborn, such as respiratory distress, jitteriness, feeding difficulties, or seizures. These symptoms may require medical support or prolonged hospitalization. There is also a potential risk of persistent pulmonary hypertension of the newborn (PPHN) when certain antidepressants are used late in pregnancy. If you are pregnant or planning to become pregnant, a healthcare provider can help weigh the risks of the medication against the risks of untreated depression during pregnancy. It is generally advised not to stop taking the medication abruptly without medical guidance. Breastfeeding It is not known whether Viibryd passes into human breast milk. While animal studies have shown the drug is present in rat milk, data in humans is lacking. Decisions regarding breastfeeding while taking this medication should involve a discussion with a healthcare professional to consider the health benefits of breastfeeding for the infant and the clinical need for the medication for the mother.

Q: What is the FDA approval status of Viibryd?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Viibryd (vilazodone hydrochloride) in January 2011. It is indicated for the treatment of major depressive disorder (MDD) in adults. The medication is classified as a selective serotonin reuptake inhibitor (SSRI) and a 5-HT1A receptor partial agonist. Boxed Warning Viibryd contains a boxed warning, which is the FDA's most serious safety alert. This warning states that antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. Healthcare providers are advised to monitor patients closely for clinical worsening or unusual changes in behavior, especially during the first few months of treatment or after dosage changes. Viibryd is not approved for use in pediatric patients. Generic Availability The FDA approved the first generic versions of Viibryd in 2022. These generic vilazodone tablets are required to meet the same quality and safety standards as the brand-name drug. Viibryd is a prescription-only medication and is not classified as a controlled substance.

Question 1

What is Viibryd?

Accepted Answer

Viibryd is a brand-name medication containing the active ingredient vilazodone. It is classified as an antidepressant that works as both a selective serotonin reuptake inhibitor and a partial serotonin receptor agonist.

The medication functions by increasing the activity of serotonin, a neurotransmitter in the brain that helps maintain emotional balance. By influencing these chemical pathways, Viibryd helps regulate mood and mental health.

Question 2

What is Viibryd used for?

Accepted Answer

Viibryd is used to treat major depressive disorder.

Question 3

How does Viibryd work?

Accepted Answer

Mechanism of Action

Viibryd (vilazodone) is classified as both a selective serotonin reuptake inhibitor (SSRI) and a partial serotonin agonist. While the exact way it works to treat depression is not fully understood, it is believed to affect the brain's chemical messengers in the following ways:

Increasing Serotonin Levels: Like other SSRIs, Viibryd prevents the brain from reabsorbing serotonin too quickly. This allows more serotonin to remain available to transmit signals between nerve cells.
Targeting Specific Receptors: Viibryd also binds to specific serotonin receptors called 5-HT1A receptors. By acting as a partial agonist at these sites, it may help further modulate serotonin activity in the brain.

Serotonin is a natural substance that helps maintain mental balance. By enhancing serotonin activity, Viibryd helps improve mood and reduce the symptoms of major depressive disorder.

Question 4

What are the active ingredients in Viibryd?

Accepted Answer

The active ingredient in Viibryd is vilazodone.

Question 5

What are the side effects of Viibryd?

Accepted Answer

Common side effects of Viibryd may include:

Diarrhea
Nausea
Insomnia

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Viibryd?

Accepted Answer

Viibryd belongs to the SSRI and 5-HT1A receptor partial agonist drug class.

Question 7

What is the dosage of Viibryd and how do I take it?

Accepted Answer

How to Take Viibryd

Viibryd is a tablet taken by mouth, usually once per day. It is important to follow the instructions on your prescription label and take the medication exactly as directed by your healthcare provider. To help you remember your dose, try to take it at the same time every day.

Taking with Food

You must take Viibryd with food. Taking this medication on an empty stomach can significantly reduce the amount of medicine your body absorbs, which may make the treatment less effective.

Missed Dose

If you miss a dose of Viibryd, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

General Instructions

Swallow the tablets whole; do not crush or chew them unless instructed otherwise by a healthcare professional.
Continue taking the medication even if you begin to feel better.
Do not stop taking this medication without first consulting your doctor, as they may want to gradually reduce your dose.

Question 8

Is Viibryd safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Research regarding the use of Viibryd during pregnancy is limited. Taking similar antidepressant medications during the third trimester may lead to complications in the newborn, such as respiratory distress, jitteriness, feeding difficulties, or seizures. These symptoms may require medical support or prolonged hospitalization. There is also a potential risk of persistent pulmonary hypertension of the newborn (PPHN) when certain antidepressants are used late in pregnancy.

If you are pregnant or planning to become pregnant, a healthcare provider can help weigh the risks of the medication against the risks of untreated depression during pregnancy. It is generally advised not to stop taking the medication abruptly without medical guidance.

Breastfeeding

It is not known whether Viibryd passes into human breast milk. While animal studies have shown the drug is present in rat milk, data in humans is lacking. Decisions regarding breastfeeding while taking this medication should involve a discussion with a healthcare professional to consider the health benefits of breastfeeding for the infant and the clinical need for the medication for the mother.

Question 9

What forms and strengths does Viibryd come in?

Accepted Answer

Viibryd is provided as a film-coated tablet intended for oral administration. These tablets are taken by mouth with food.

Generic versions of vilazodone hydrochloride are also available in tablet form. The appearance of the tablets, including color and shape, may vary between the brand-name product and generic equivalents.

Question 10

What is the FDA approval status of Viibryd?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Viibryd (vilazodone hydrochloride) in January 2011. It is indicated for the treatment of major depressive disorder (MDD) in adults. The medication is classified as a selective serotonin reuptake inhibitor (SSRI) and a 5-HT1A receptor partial agonist.

Boxed Warning

Viibryd contains a boxed warning, which is the FDA's most serious safety alert. This warning states that antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. Healthcare providers are advised to monitor patients closely for clinical worsening or unusual changes in behavior, especially during the first few months of treatment or after dosage changes. Viibryd is not approved for use in pediatric patients.

Generic Availability

The FDA approved the first generic versions of Viibryd in 2022. These generic vilazodone tablets are required to meet the same quality and safety standards as the brand-name drug. Viibryd is a prescription-only medication and is not classified as a controlled substance.

Question 11

What should I know about Viibryd and withdrawal?

Accepted Answer

Withdrawal Symptoms

If you stop taking Viibryd abruptly, you may experience a range of physical and mental symptoms known as discontinuation syndrome. These symptoms can include:

Mood and mental changes: Irritability, agitation, anxiety, confusion, and hypomania.
Physical sensations: Dizziness, headache, sweating, nausea, and "electric shock" sensations (paresthesia).
Sleep and energy: Tiredness and difficulty falling or staying asleep.
Other effects: Ringing in the ears (tinnitus) and, in rare cases, seizures.

Safe Discontinuation

To avoid or minimize these symptoms, healthcare providers typically recommend gradually reducing your dose over a period of time rather than stopping the medication all at once. This process is known as tapering. Always follow your healthcare provider's specific instructions for ending treatment to ensure your safety and comfort.

Viibryd

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Viibryd

Hospitals.net Disclosure